Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

552 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Integration of pathological criteria and immunohistochemical evaluation for invasive lobular carcinoma diagnosis: recommendations from the European Lobular Breast Cancer Consortium.
De Schepper M, Koorman T, Richard F, Christgen M, Vincent-Salomon A, Schnitt SJ, van Diest PJ, Zels G, Mertens F, Maetens M, Vanden Bempt I, Harbeck N, Nitz U, Gräser M, Kümmel S, Gluz O, Weynand B, Floris G, Derksen PW, Desmedt C; Pathology Working group of the European Lobular Breast Cancer Consortium. De Schepper M, et al. Among authors: mertens f. Mod Pathol. 2024 Apr 17:100497. doi: 10.1016/j.modpat.2024.100497. Online ahead of print. Mod Pathol. 2024. PMID: 38641322 Free article.
Interprofessional education for healthcare professionals. A BEME realist review of what works, why, for whom and in what circumstances in undergraduate health sciences education: BEME Guide No. 83.
Krystallidou D, Kersbergen MJ, de Groot E, Fluit CRMG, Kuijer-Siebelink W, Mertens F, Oosterbaan-Lodder SCM, Scherpbier N, Versluis MAC, Pype P. Krystallidou D, et al. Among authors: mertens f. Med Teach. 2024 Mar 21:1-18. doi: 10.1080/0142159X.2024.2314203. Online ahead of print. Med Teach. 2024. PMID: 38513054
Transcriptomic subtyping of malignant peripheral nerve sheath tumours highlights immune signatures, genomic profiles, patient survival and therapeutic targets.
Høland M, Berg KCG, Eilertsen IA, Bjerkehagen B, Kolberg M, Boye K, Lingjærde OC, Guren TK, Mandahl N, van den Berg E, Palmerini E, Smeland S, Picci P, Mertens F, Sveen A, Lothe RA. Høland M, et al. Among authors: mertens f. EBioMedicine. 2023 Nov;97:104829. doi: 10.1016/j.ebiom.2023.104829. Epub 2023 Oct 12. EBioMedicine. 2023. PMID: 37837931 Free PMC article.
Diagnostic Yield From a Nationwide Implementation of Precision Medicine for all Children With Cancer.
Wadensten E, Wessman S, Abel F, Diaz De Ståhl T, Tesi B, Orsmark Pietras C, Arvidsson L, Taylan F, Fransson S, Vogt H, Poluha A, Pradhananga S, Hellberg M, Lagerstedt-Robinson K, Raj Somarajan P, Samuelsson S, Orrsjö S, Maqbool K, Henning K, Strid T, Ek T, Fagman H, Olsson Bontell T, Martinsson T, Puls F, Kogner P, Wirta V, Pronk CJ, Wille J, Rosenquist R, Nistér M, Mertens F, Sabel M, Norén-Nyström U, Grillner P, Nordgren A, Ljungman G, Sandgren J, Gisselsson D; Genomic Medicine Sweden Childhood Cancer Working Group. Wadensten E, et al. Among authors: mertens f. JCO Precis Oncol. 2023 Jun;7:e2300039. doi: 10.1200/PO.23.00039. JCO Precis Oncol. 2023. PMID: 37384868 Free PMC article.
Intra-patient and inter-metastasis heterogeneity of HER2-low status in metastatic breast cancer.
Geukens T, De Schepper M, Richard F, Maetens M, Van Baelen K, Mahdami A, Nguyen HL, Isnaldi E, Leduc S, Pabba A, Zels G, Mertens F, Vander Borght S, Smeets A, Nevelsteen I, Punie K, Neven P, Wildiers H, Van Den Bogaert W, Floris G, Desmedt C. Geukens T, et al. Among authors: mertens f. Eur J Cancer. 2023 Jul;188:152-160. doi: 10.1016/j.ejca.2023.04.026. Epub 2023 May 6. Eur J Cancer. 2023. PMID: 37247580 Free article.
552 results